Working… Menu
Help guide our efforts to modernize
Send us your comments by March 14, 2020.
Trial record 1 of 3 for:    Dudek | Mesothelioma
Previous Study | Return to List | Next Study

Phase II Nivolumab and Ramucirumab for Patients With Previously-Treated Mesothelioma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03502746
Recruitment Status : Recruiting
First Posted : April 19, 2018
Last Update Posted : August 16, 2019
HealthPartners Institute Regions Cancer Care Center
Eli Lilly and Company
Bristol-Myers Squibb
Information provided by (Responsible Party):
Arkadiusz Z. Dudek, MD, Hoosier Cancer Research Network

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : June 2020
Estimated Study Completion Date : June 2021